Skip to main content
Top
Published in: Pediatric Cardiology 6/2005

01-12-2005

Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia

Authors: B.T. Yilmaz, B. Alioglu, E. Ozyurek, H.T. Akay, S. Mercan, N. Ozbek

Published in: Pediatric Cardiology | Issue 6/2005

Login to get access

Abstract

Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
Literature
1.
go back to reference Al Douri, M, Shafi, T, Al Khudairi, D, et al. 2000Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgeryBlood Coag Fibrinolysis11S121S127 Al Douri, M, Shafi, T, Al Khudairi, D,  et al. 2000Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgeryBlood Coag Fibrinolysis11S121S127
2.
go back to reference D’Oiron, R, Menart, C, Trzeciak, MC, et al. 2000Use of recombinant factor VIIa in patients with inherited type I Glanzmann’s thrombasthenia undergoing invasive proceduresThromb Haemost83844847 D’Oiron, R, Menart, C, Trzeciak, MC,  et al. 2000Use of recombinant factor VIIa in patients with inherited type I Glanzmann’s thrombasthenia undergoing invasive proceduresThromb Haemost83844847
3.
go back to reference Gill, R, Herbertson, M, Diprose, P 2004New alternatives for control of severe cardiac surgical bleedingSemin Hematol41174CrossRef Gill, R, Herbertson, M, Diprose, P 2004New alternatives for control of severe cardiac surgical bleedingSemin Hematol41174CrossRef
4.
go back to reference Hedner, U 2000Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000Semin Thromb Hemost26363366PubMed Hedner, U 2000Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000Semin Thromb Hemost26363366PubMed
5.
go back to reference Levine, SP 1999Qualitative disorders of platelet function:Lee, GRFoerster, JLukens, J eds. Wintrobe’s Clinical Hematology, Vol. 1999Lippincott Williams & WilkinsBaltmore16631666 Levine, SP 1999Qualitative disorders of platelet function:Lee, GRFoerster, JLukens, J eds. Wintrobe’s Clinical Hematology, Vol. 1999Lippincott Williams & WilkinsBaltmore16631666
6.
go back to reference Patel, RK, Savidge, GF, Rangarajan, S 2001Use of recombinant factor VIIa for postoperative haemorrhage in a patient with Glanzmann’s thrombasthenia and human leucocyte antigen antibodiesBr J Hematol114245246CrossRef Patel, RK, Savidge, GF, Rangarajan, S 2001Use of recombinant factor VIIa for postoperative haemorrhage in a patient with Glanzmann’s thrombasthenia and human leucocyte antigen antibodiesBr J Hematol114245246CrossRef
7.
go back to reference Poon, MC, Demers, C, Jobin, F, Wu, JW 1999Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombastheniaBlood9439513953PubMed Poon, MC, Demers, C, Jobin, F, Wu, JW 1999Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombastheniaBlood9439513953PubMed
8.
go back to reference Santagostino, E, Morfini, M, Rocino, A, et al. 2001Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitorsThromb Haemost86954958PubMed Santagostino, E, Morfini, M, Rocino, A,  et al. 2001Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitorsThromb Haemost86954958PubMed
9.
go back to reference Schulman, S 1998Safety, efficacy and lessons from continuous infusion with rFVIIa, rFVIIa-CI groupHaemophilia4564567CrossRefPubMed Schulman, S 1998Safety, efficacy and lessons from continuous infusion with rFVIIa, rFVIIa-CI groupHaemophilia4564567CrossRefPubMed
10.
go back to reference Shapiro, AD, Gilchrist, GS, Hoots, WK, Cooper, HA, Gastineau, DA 1998Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in hemophilia patients with inhibitors undergoing surgeryThromb Haemost80773778PubMed Shapiro, AD, Gilchrist, GS, Hoots, WK, Cooper, HA, Gastineau, DA 1998Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in hemophilia patients with inhibitors undergoing surgeryThromb Haemost80773778PubMed
11.
go back to reference Sheth, S, Dimichele, D, Lee, M, et al. 2001Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIaHemophilia7227232CrossRef Sheth, S, Dimichele, D, Lee, M,  et al. 2001Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIaHemophilia7227232CrossRef
12.
go back to reference Smith, MP, Ludlam, CA, Collins, PW, et al. 2001Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated FVIIThromb Haemost86949953PubMed Smith, MP, Ludlam, CA, Collins, PW,  et al. 2001Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated FVIIThromb Haemost86949953PubMed
13.
go back to reference Tengborn, L, Petruson, B 1996A patient with Glanzmann thrombasthenia and epistaxis succesfully treated with recombinant factor VIIaThromb Haemost75981982PubMed Tengborn, L, Petruson, B 1996A patient with Glanzmann thrombasthenia and epistaxis succesfully treated with recombinant factor VIIaThromb Haemost75981982PubMed
Metadata
Title
Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia
Authors
B.T. Yilmaz
B. Alioglu
E. Ozyurek
H.T. Akay
S. Mercan
N. Ozbek
Publication date
01-12-2005
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 6/2005
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-004-0919-7

Other articles of this Issue 6/2005

Pediatric Cardiology 6/2005 Go to the issue